Rheumatology — Biologic Infusions, Fully Reimbursed

Proven Results

• 33% Average Revenue Increase
• 95.4% First-Pass Claim Rate
• 46.5% Reduction in Denials
• 16.2 Days Faster Payment Collection

Common Billing Challenges

Biologic Medication Billing

High-cost biologic drugs require complex billing with proper J-codes, waste documentation, and medical necessity justification.

Prior Authorization Complexity

Biologic therapies and specialty medications require extensive prior authorizations with detailed clinical documentation.

Infusion Therapy Time Tracking

Infusion billing requires accurate time documentation, proper hydration coding, and push vs infusion distinction.

Buy and Bill Drug Management

Managing inventory, acquisition costs, and billing for physician-administered drugs requires specialized tracking.

Multiple Procedure Bundling

Joint injections and office procedures often performed together require proper modifiers to prevent bundling.

Specialty Pharmacy Coordination

Coordination between medical benefit and pharmacy benefit for specialty drugs creates billing confusion.

Our Solutions

Rheumatology Billing Specialists

Our team includes certified coders with specialized training in rheumatology procedures, biologic billing, and infusion therapy.

• Expert J-code selection for biologic drugs
• Proper infusion CPT coding (96365-96368)
• Joint injection billing expertise
• Specialty drug benefit determination

Prior Authorization Management

Dedicated team handles all prior authorizations for biologic therapies and specialty medications with clinical documentation support.

• Streamlined prior authorization process
• Clinical documentation preparation
• Appeal management for denials
• Faster treatment initiation

Biologic Drug Revenue Optimization

Maximize reimbursements through proper drug coding, waste documentation, and buy-and-bill management.

• Accurate J-code and NDC billing
• Waste and overfill documentation
• ASP pricing verification
• Drug acquisition cost tracking

Infusion Center Billing Expertise

Comprehensive billing support for infusion centers with time-based coding and facility fee management.

• Sequential infusion coding
• Concurrent infusion management
• Hydration and push billing
• Observation and prolonged services

Specialized Services

Biologic Infusion Billing

Expert billing for Remicade, Orencia, Rituxan, and other biologic infusion therapies with proper J-codes.

• Biologic drug coding
• Waste documentation
• Time-based billing
• Medical necessity support

Joint Injection Procedures

Specialized billing for therapeutic joint injections with proper CPT codes and modifier application.

• Joint injection coding
• Aspiration billing
• Ultrasound guidance
• Multiple procedure modifiers

Infusion Center Management

Complete billing support for infusion centers including drug billing, administration codes, and facility fees.

• Infusion administration
• Hydration services
• Drug acquisition
• Concurrent therapy billing

Specialty Drug Authorization

Prior authorization and appeals management for specialty rheumatology medications and biologics.

• Prior authorization
• Medical policy review
• Denial appeals
• Specialty pharmacy coordination

Common CPT Codes Reference

Key codes include 99214 (Office visit, established patient, 30–39 min), 99215 (Office visit, established patient, 40–54 min), 20610 (Aspiration and/or injection, major joint or bursa), 20605 (Aspiration and/or injection, intermediate joint), 96365 (IV infusion, initial, up to 1 hour), 96366 (IV infusion, each additional hour (add-on)), 96413 (Chemotherapy administration, IV infusion technique, up to 1 ), 76942 (Ultrasound guidance for needle placement, imaging supervisio), 76536 (Ultrasound, soft tissues of head and neck), 85025 (Complete blood count with differential). Proper code selection requires understanding of bundling rules, NCCI edits, and modifier usage.

Expert Billing Insights

Biologic Therapy Prior Authorization: Documentation That Gets Approved

Biologic medications for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and lupus represent the highest drug spend in rheumatology. Prior authorization for biologics consistently requires documentation of disease severity (DAS28 scores, CDAI, BASDAI), failure of conventional DMARDs (methotrexate, hydroxychloroquine), baseline labs, and TB screening. Incomplete documentation is the primary cause of biologic prior auth denials. Step therapy — which may require failure of two different traditional DMARDs — varies by payer.

• Document disease activity scores at every visit: DAS28, CDAI, RAPID3, or BASDAI
• DMARD failure documentation: dates of trial, doses used, and reasons for discontinuation
• Baseline TB screening (QuantiFERON or TST), hepatitis B/C testing required for all biologics
• Reauthorization: document clinical response or remission status with objective scores

Joint Injection Billing with Ultrasound Guidance

Rheumatologists performing ultrasound-guided joint injections can bill both the injection code and the imaging guidance code (76942) when they personally provide the ultrasound guidance and document the saved images. Point-of-care ultrasound in rheumatology has expanded dramatically and represents significant additional revenue per injection encounter. Documentation must include the indication for guidance, the real-time ultrasound-guided needle placement, and images saved in the patient record.

• Bill 20610 (major joint) or 20605 (intermediate) + 76942 (ultrasound guidance)
• Saved ultrasound images are required — document needle visualization in the procedure note
• One ultrasound guidance code per session regardless of number of joints injected
• POCU training and credentialing: document competency for payer medical necessity standards

Infusion Center Operations: Biologic Drug Administration Billing

Rheumatology in-office infusion centers for IV biologics (Remicade, Orencia, Rituxan, Benlysta) generate substantial revenue through the buy-and-bill model. This involves purchasing the biologic at WAC or GPO pricing, administering it under physician supervision, and billing the drug (J-code) plus administration (96365-series) to insurance. The margin between drug acquisition cost and insurance reimbursement is the practice's drug revenue. Site-of-service differences between physician office (POS 11) and hospital outpatient (POS 22) significantly affect reimbursement.

• Document infusion start/stop time, nursing monitoring notes, and any adverse reactions
• Drug J-code billed at units based on dose administered — not vial size
• Single-dose vial waste: document remaining waste for Medicare; bill waste units appropriately
• Pre-medications (antihistamines, steroids): bill separately with appropriate J-codes

Payer-Specific Billing Tips

Medicare Part B

• Biologics administered in office are covered under Part B — self-administered biologics go to Part D
• Medicare biosimilar policies evolving — biosimilar may be substituted; document clinical rationale if brand required
• DMEPOS biologics (anakinra injection kits for self-administration) bill differently from infused agents
• MIPS quality measures for rheumatology include disease activity documentation and DMARD prescribing

Medicaid

• Biologic prior auth requirements are often more restrictive under Medicaid than commercial
• Step therapy requirements: some state Medicaid programs require 3 DMARD failures before biologic auth
• Pediatric rheumatology biologics (JIA): coverage available under EPSDT with less step therapy
• Managed Medicaid plans may require specialist-to-specialist referrals for biologic continuation

Commercial Payers

• Commercial biologic step therapy: typically 2+ DMARD failures required (methotrexate + one other)
• Many plans have preferred biologic lists — prescribing off-formulary may require exception
• Specialty pharmacy carve-outs: some plans require drug dispensed through their specialty pharmacy
• Annual reauthorization: submit DAS28/CDAI scores and response documentation at least 60 days before expiration

Rheumatology Infusion Best Practices

• Track patient authorization expiration dates — expired auth causes immediate claim denial
• Bill drug wastage to protect practice revenue on expensive single-dose vials
• Document pre-medication administration with separate drug and administration codes
• Maintain detailed infusion logs: start time, stop time, nursing assessments every 15–30 minutes

Related Billing Resources

• Orthopedic Billing
• Pain Management Billing
• Dermatology Billing
• Prior Authorization Services
• Medical Coding Services
• CPT Codes Reference Guide
• ICD-10 Codes Reference

Key Services

• rheumatology billing
• arthritis billing
• autoimmune disease billing
• infusion therapy billing
• joint injection billing
• biologic drug billing
• J-code billing